Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing investor interest with its promising upside potential of 50.12%, based on current analyst ratings. As a commercial-stage biopharmaceutical company, Catalyst is dedicated to..
Amneal Pharmaceuticals, Inc. (AMRX) is capturing the attention of investors with its promising financial outlook and a strong consensus of buy ratings from analysts. With a market capitalization of $4.08..
Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company headquartered in San Diego, California, has been capturing investor attention with its promising drug pipeline and significant upside potential. Operating in..
Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company, has been capturing investor attention with its promising development pipeline in the healthcare sector. Based in New York, Immunovant focuses on creating..
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a notable player in the biotechnology sector, with a dedicated focus on developing treatments for rare and ultra-rare genetic diseases. Headquartered in Novato,..
For investors with a keen eye on the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) presents an intriguing opportunity. Despite facing challenges typical of clinical-stage biotech companies, Arcellx’s innovative approach and..
Investors looking for opportunities in the healthcare sector might find PROCEPT BioRobotics Corporation (NASDAQ: PRCT) a compelling prospect, especially given its projected upside potential of 61.91%. As a key player..
Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is making waves with its innovative approach to physician enablement. With a market capitalization of $2.88 billion,..
Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices industry, has positioned itself as an intriguing investment opportunity within the healthcare sector. Headquartered in Boston, Massachusetts, Haemonetics stands..
DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a heavyweight in the dental equipment and healthcare consumables sector, presents a compelling case for investors who balance risk with income potential. Operating out of..
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a notable player in the biotechnology sector, is capturing investor attention with its robust pipeline of treatments targeting central nervous system (CNS) disorders and rare..
